Scholarlink

<p>Tuberculosis (TB), caused by <i>Mycobacterium tuberculosis</i>, still globally threatens human health. With the emergence of multidrug-resistant strains, there is an imperative need to discover new anti-TB agents and identify novel drug targets. Here, we report that the compound ACA, namely 3-azidothiophene-2-carboxylic acid, can kill <i>M. tuberculosis</i> by targeting the bacterial cell wall core assembling process. Whole-genome sequencing of spontaneous ACA-resistant mutants identified single-nucleotide variants in the <i>cpsA2</i> ligase gene responsible for the covalent attachment of arabinogalactan and peptidoglycan. The cell wall of <i>cpsA2</i> or its homolog <i>cpsA1-</i>deleted mutant H37Ra strains show increased permeability and drug sensitivity, which is similar to the ACA-treated mycobacteria. Both <i>cpsA1</i> and <i>cpsA2</i> could reverse the resistant phenotype of ACA-resistant mutants and the growth defects of the Δ<i>cpsA1</i> H37Ra strain. ACA can directly bind CpsA1 and CpsA2 to inhibit significantly the pyrophosphatase activity of CpsA1 and CpsA2. Our results suggest that ACA may disturb the cell wall core assembling process and kill <i>M. tuberculosis</i> by targeting CpsA1 and CpsA2, which provide potential candidate drug target for controlling drug-resistant TB.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

ACA kills Mycobacterium tuberculosis and M. bovis by targeting cell wall core assembling protein CpsA

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月26日

查看全文
  • Feng Huang,
  • Mengcong Shi,
  • Liu Chen,
  • Xiaohui Li,
  • Zixin Wang,
  • Dong Jiang,
  • Junfeng Chen,
  • Hua Zhang,
  • Zheng-Guo He

摘要

Tuberculosis (TB), caused by Mycobacterium tuberculosis, still globally threatens human health. With the emergence of multidrug-resistant strains, there is an imperative need to discover new anti-TB agents and identify novel drug targets. Here, we report that the compound ACA, namely 3-azidothiophene-2-carboxylic acid, can kill M. tuberculosis by targeting the bacterial cell wall core assembling process. Whole-genome sequencing of spontaneous ACA-resistant mutants identified single-nucleotide variants in the cpsA2 ligase gene responsible for the covalent attachment of arabinogalactan and peptidoglycan. The cell wall of cpsA2 or its homolog cpsA1-deleted mutant H37Ra strains show increased permeability and drug sensitivity, which is similar to the ACA-treated mycobacteria. Both cpsA1 and cpsA2 could reverse the resistant phenotype of ACA-resistant mutants and the growth defects of the ΔcpsA1 H37Ra strain. ACA can directly bind CpsA1 and CpsA2 to inhibit significantly the pyrophosphatase activity of CpsA1 and CpsA2. Our results suggest that ACA may disturb the cell wall core assembling process and kill M. tuberculosis by targeting CpsA1 and CpsA2, which provide potential candidate drug target for controlling drug-resistant TB.